These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 19549748

  • 1. Lack of regulation of 11beta-hydroxysteroid dehydrogenase type 1 during short-term manipulation of GH in patients with hypopituitarism.
    Sigurjonsdottir HA, Andrew R, Stimson RH, Johannsson G, Walker BR.
    Eur J Endocrinol; 2009 Sep; 161(3):375-80. PubMed ID: 19549748
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Growth hormone, insulin-like growth factor-I and the cortisol-cortisone shuttle.
    Stewart PM, Toogood AA, Tomlinson JW.
    Horm Res; 2001 Sep; 56 Suppl 1():1-6. PubMed ID: 11786677
    [Abstract] [Full Text] [Related]

  • 4. The effects of growth hormone deficiency and replacement on glucocorticoid exposure in hypopituitary patients on cortisone acetate and hydrocortisone replacement.
    Swords FM, Carroll PV, Kisalu J, Wood PJ, Taylor NF, Monson JP.
    Clin Endocrinol (Oxf); 2003 Nov; 59(5):613-20. PubMed ID: 14616886
    [Abstract] [Full Text] [Related]

  • 5. DIFFERENTIAL REGULATION OF 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ACTIVITY IN PATIENTS WITH DIFFERING ETIOLOGIES OF HYPOPITUITARISM.
    Agha A, Behan LA, Forde H, Taylor NF, Smith D, Thompson CJ, Drake WM, Monson JP.
    Endocr Pract; 2018 Oct 02; 24(10):875-881. PubMed ID: 29975580
    [Abstract] [Full Text] [Related]

  • 6. Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonists on 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue in men.
    Wake DJ, Stimson RH, Tan GD, Homer NZ, Andrew R, Karpe F, Walker BR.
    J Clin Endocrinol Metab; 2007 May 02; 92(5):1848-56. PubMed ID: 17327378
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11 beta-hydroxysteroid dehydrogenase activity.
    Gelding SV, Taylor NF, Wood PJ, Noonan K, Weaver JU, Wood DF, Monson JP.
    Clin Endocrinol (Oxf); 1998 Feb 02; 48(2):153-62. PubMed ID: 9579226
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Quantification of 11β-hydroxysteroid dehydrogenase 1 kinetics and pharmacodynamic effects of inhibitors in brain using mass spectrometry imaging and stable-isotope tracers in mice.
    Cobice DF, Livingstone DEW, McBride A, MacKay CL, Walker BR, Webster SP, Andrew R.
    Biochem Pharmacol; 2018 Feb 02; 148():88-99. PubMed ID: 29248595
    [Abstract] [Full Text] [Related]

  • 11. Growth hormone replacement inhibits renal and hepatic 11 beta-hydroxysteroid dehydrogenases in ACTH-deficient patients.
    Walker BR, Andrew R, MacLeod KM, Padfield PL.
    Clin Endocrinol (Oxf); 1998 Aug 02; 49(2):257-63. PubMed ID: 9828916
    [Abstract] [Full Text] [Related]

  • 12. Tissue specific regulation of glucocorticoids in severe obesity and the response to significant weight loss following bariatric surgery (BARICORT).
    Woods CP, Corrigan M, Gathercole L, Taylor A, Hughes B, Gaoatswe G, Manolopoulos K, Hogan AE, O'Connell J, Stewart PM, Tomlinson JW, O'Shea D, Sherlock M.
    J Clin Endocrinol Metab; 2015 Apr 02; 100(4):1434-44. PubMed ID: 25603461
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cortisol release from adipose tissue by 11beta-hydroxysteroid dehydrogenase type 1 in humans.
    Stimson RH, Andersson J, Andrew R, Redhead DN, Karpe F, Hayes PC, Olsson T, Walker BR.
    Diabetes; 2009 Jan 02; 58(1):46-53. PubMed ID: 18852329
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Extra-adrenal regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1: physiological regulator and pharmacological target for energy partitioning.
    Walker BR.
    Proc Nutr Soc; 2007 Feb 02; 66(1):1-8. PubMed ID: 17343766
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of growth hormone replacement on cortisol metabolism in hypopituitary patients treated with cortisone acetate.
    Beentjes JA, Kerstens MN, Dullaart RP.
    Scand J Clin Lab Invest; 2001 Jul 02; 61(4):277-86. PubMed ID: 11465341
    [Abstract] [Full Text] [Related]

  • 20. Modulation of glucocorticoid metabolism by the growth hormone - IGF-1 axis.
    Agha A, Monson JP.
    Clin Endocrinol (Oxf); 2007 Apr 02; 66(4):459-65. PubMed ID: 17371460
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.